Roivant Sciences Ltd (NAS:ROIVW)
$ 2.75 -0.11 (-3.85%) Market Cap: 0 Enterprise Value: 0 PE Ratio: 0 PB Ratio: 5.42 GF Score: 55/100

Roivant Sciences Ltd at Leerink Global Healthcare Conference Transcript

Mar 11, 2026 / 12:40PM GMT
David Risinger
Leerink Partners LLC - Analyst

Hi, everybody. So my name is Dave Risinger. On behalf of Leerink Partners. I just wanted to thank you for joining our conference. It's very much my pleasure to introduce Matt Gline, CEO of Roivant.

He's just putting a little sugar in his coffee and then we'll get started. But I really appreciate you being here and his team members Richard and -- in the audience as well.

So I thought it would be great for you to just maybe kick off Matt with some opening comments on the business prospects, you've had a tremendous run of good news and hoping for good -- for more good news ahead, but I would love you to start with some opening comments.

Matthew Gline
Roivant Sciences GmbH - Chief Executive Officer

Yes. Thanks, Dave. Thanks for having us. It's a great venue for a conference. I think the best in Miami at present.

So thanks, Dave. Thank you for having us.

Look, it's been -- I don't know what's hard looking at over the room to know exactly who's got what level of familiarity, but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot